Day: May 20, 2022

Omer, Israel, May 20, 2022 (GLOBE NEWSWIRE) — ScoutCam Inc. (OTCQB: SCTC) (“ScoutCam” or the “Company”), a leading provider of image based solutions (including cloud and AI image processing) to the Condition Based Maintenance (CBM) and the Predictive Maintenance (PdM) markets, as well as a leading provider of image based solutions to the medical device market, today announced that an interview with Company CEO Yovav Sameah will air on The RedChip Money Report® on Bloomberg TV, May 21, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the United States. The RedChip Money Report® delivers insightful commentary on small-cap investing, interviews with Wall Street analysts and financial book reviews, as well as featured interviews with executives of public companies. “We...

HOUSTON, TX, May 20, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – D3eSports, a division of StemGen Inc., (OTC: SGNI), today announced another new team for the 2022 D3eSports Cup Championship. Team Jamaica will join previously announced corporate teams for the exciting global esports championship.  Team Jamaica is an alliance with Jacqui’s Gourmet. The team is managed by Jacqui’s Gourmet Founder Jacqui Francis, former Caterer to the Prime Minister of Jamaica. Jacqui’s Gourmet offers delicious, savory rubs, seasonings and sauces featuring exotic flavors of the finer side of gourmet Jamaican cuisine, created by Francis. Additionally, she is an author of the cookbook, “Nyam Thyme”, featuring scrumptious recipes with a Jamaican-style cooking flavor.  The Team Jamaica esports entity is partnering with local businesses to offer exciting...

First Gene Therapy Directly Infused into the Brain to be Administered with ClearPoint’s SmartFlow® Cannula SOLANA BEACH, Calif., May 20, 2022 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates partner PTC Therapeutics for receiving a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending its gene therapy treatment Upstaza™ (eladocagene exuparvovec), formerly PTC-AADC, for the treatment of aromatic L-amino acid decarboxylase (AADC) deficiency. The use of ClearPoint Neuro’s proprietary CE Marked SmartFlow® Neuro Ventricular Cannula for minimally invasive infusion of the gene therapy is included in the submission for administration...

LOS ANGELES, CA, May 20, 2022 (GLOBE NEWSWIRE) — Social Life Network, Inc. (OTC: WDLF) and Decentral Life, a division of the company, announced today that it has launched a new QR Code add-on application for its Digital Wallet and Payment Platform, allowing mobile retailers to easily receive cryptocurrency payments that can be instantly tracked in their favorite accounting software, like QuickBooks or NetSuite. “As an add-on to our Digital Wallet and Payment Platform, which already works seamlessly with software like QuickBooks, NetSuite and many other popular accounting applications, the QR Code system add-on allows for easier accounting of purchases with cryptocurrency,” said CEO, Ken Tapp. “I believe the QR Code add-on to be a critical feature for mobile customers paying retailers face-to-face, at trade shows, expos, and conferences....

SarahCare Beta Testing New At Home Health Service BLUE ISLAND, Ill., May 20, 2022 (GLOBE NEWSWIRE) — Innovative MedTech, Inc. (the “Company”) (OTC: IMTH), a provider of health and wellness services, today announced that its wholly owned subsidiary, SarahCare, will be beta testing a home health service in which SarahCare will deliver a new standard of care to residents surrounding a few of its locations. “We are very excited about beta testing, with a very select number of SarahCare centers, a home health care service which will monitor our participants at their homes. We are committed to putting our participants and their families first, and we believe that this is another way in which we can do that, while offering an enhanced quality of services that should be convenient and cost effective,” said Dr. Merle Griff, CEO of SarahCare. Dr....

RNS ANNOUCEMENT FORESIGHT ENTERPRISE VCT PLC (Company)Legal Entity Identity number: 213800MWJNR3WZZ3ZP42Supplementary Prospectus The board of the Company (Board) announce that it has published a supplementary prospectus (Supplementary Prospectus) relating to the offer for subscription to raise up to £20 million (with an over-allotment facility to raise up to a further £10 million) through the issue of new shares (Offer). The Supplementary Prospectus refers to the publication of the Company’s annual report and accounts for the year ended 31 December 2021 (2021 Accounts), certain information from which is incorporated by reference into the Supplementary Prospectus. Copies of the Supplementary Prospectus and the 2021 Accounts have been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National...

FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will be virtually participating in the H.C. Wainwright Global Investment Conference being held May 23 – 26, 2022. Company management will also be participating in virtual one-on-one meetings throughout the conference.H.C. Wainwright Global Investment Conference   Presentation: Presentation available Tuesday, May 24, 2022 at 7:00 am ET   Presenter: Glenn Mattes, President and Chief Executive Officer   Webcast: https://journey.ct.events/view/5f089b49-225b-422b-aaa9-86eec6c06b4aPlease...

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test throughout the European Union as well as other countries that recognise the CE Mark designation. In addition to its ease-of-use and impressive speed to result, in extensive clinical trails the test has demonstrated excellent 99% sensitivity and 99% specificity which are accuracy levels superior to many of the tests currently on the market. The test uses an anterior nasal swab sample rather than the more invasive nasopharangeal swab, providing a more comfortable patient experience. The test also has several features that benefit the user including a convenient pre-filled...